Eiichiro Suzuki
Denmark Hill
London, ENG, United Kingdom
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 94 publications
Impact of clinically diagnosed liver cirrhosis in patients with intrahepatic cholangiocarcinoma treated with systemic chemotherapy: a subgroup analysis of JCOG1113.
Journal: Japanese journal of clinical oncology
Published: December 15, 2024
Randomized phase II study comparing two doses of regorafenib in second-line treatment for advanced hepatocellular carcinoma.
Journal: JHEP reports : innovation in hepatology
Published: October 20, 2024
Random mutagenesis and disulfide bond formation improved thermostability in microbial transglutaminase.
Journal: Applied microbiology and biotechnology
Published: July 02, 2024
A Prospective Study Exploring the Safety and Efficacy of Lenvatinib for Patients with Advanced Hepatocellular Carcinoma and High Tumor Burden: The LAUNCH Study.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 19, 2023
Efficacy of chemotherapy for patients with metastatic or recurrent pancreatic adenosquamous carcinoma: A multicenter retrospective analysis.
Journal: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]
Published: April 17, 2022
The efficacy of contrast-enhanced computed tomography on the management of gastroesophageal varices in patients with hepatocellular carcinoma.
Journal: Scientific reports
Published: April 10, 2022
Rational design of a disulfide bridge increases the thermostability of microbial transglutaminase.
Journal: Applied microbiology and biotechnology
Published: February 19, 2022
Effect of Atezolizumab plus Bevacizumab in Patients with Hepatocellular Carcinoma Harboring CTNNB1 Mutation in Early Clinical Experience.
Journal: Journal of Cancer
Published: January 28, 2022
Liver biopsy technique in the era of genomic cancer therapies: a single-center retrospective analysis.
Journal: International journal of clinical oncology
Published: October 29, 2021
EZH1/2 inhibition augments the anti-tumor effects of sorafenib in hepatocellular carcinoma.
Journal: Scientific reports
Published: June 25, 2021
Exploring microsatellite instability in patients with advanced hepatocellular carcinoma and its tumor microenvironment.
Journal: JGH open : an open access journal of gastroenterology and hepatology
Published: June 04, 2021
Last Updated: 09/26/2026